JP2024506385A5 - - Google Patents
Info
- Publication number
- JP2024506385A5 JP2024506385A5 JP2023548874A JP2023548874A JP2024506385A5 JP 2024506385 A5 JP2024506385 A5 JP 2024506385A5 JP 2023548874 A JP2023548874 A JP 2023548874A JP 2023548874 A JP2023548874 A JP 2023548874A JP 2024506385 A5 JP2024506385 A5 JP 2024506385A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- gdc
- patient
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163149944P | 2021-02-16 | 2021-02-16 | |
| US63/149,944 | 2021-02-16 | ||
| PCT/US2022/016270 WO2022177844A1 (en) | 2021-02-16 | 2022-02-14 | Treatment of breast cancer using combination therapies comprising gdc-9545 and gdc-0077 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024506385A JP2024506385A (ja) | 2024-02-13 |
| JP2024506385A5 true JP2024506385A5 (cg-RX-API-DMAC7.html) | 2025-02-18 |
| JP7904849B2 JP7904849B2 (ja) | 2026-08-13 |
Family
ID=80953424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548874A Active JP7904849B2 (ja) | 2021-02-16 | 2022-02-14 | Gdc-9545及びgdc-0077を含む併用療法を使用する乳がんの治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230381155A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4294395B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7904849B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN117377472A (cg-RX-API-DMAC7.html) |
| ES (1) | ES3030540T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL4294395T3 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI808648B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022177844A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025538147A (ja) * | 2022-11-02 | 2025-11-26 | ペトラ・ファーマ・コーポレイション | 疾患の治療のためのホスホイノシチド3-キナーゼ(pi3k)のアロステリックポケット及びオルソステリックポケットの標的化 |
| JP2025163068A (ja) * | 2022-11-02 | 2025-10-28 | ペトラ・ファーマ・コーポレイション | 疾患の治療のためのホスホイノシチド3-キナーゼ(pi3k)のアロステリックポケット及びオルソステリックポケットの標的化 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI784255B (zh) | 2014-12-18 | 2022-11-21 | 瑞士商赫孚孟拉羅股份公司 | 四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途 |
| CN111909173B (zh) | 2015-07-02 | 2025-03-04 | 豪夫迈·罗氏有限公司 | 苯并氧氮杂䓬噁唑烷酮化合物及其使用方法 |
| CN109843882A (zh) * | 2016-06-16 | 2019-06-04 | 豪夫迈·罗氏有限公司 | 四氢-吡啶并[3,4-b]吲哚雌激素受体调节剂及其用途 |
| LT3810283T (lt) | 2018-06-21 | 2023-08-25 | F. Hoffmann-La Roche Ag | 3-((1r,3r)-1-(2,6-difluor-4-((1-(3-fluorpropil)azetidin-3- il)amino) fenil)-3-metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)- 2,2- difluorpropan-1-olio tartrato druskos kietosios formos, jų paruošimo procesas ir jų naudojimo būdai vėžiui gydyti |
| KR20210035211A (ko) * | 2018-07-23 | 2021-03-31 | 에프. 호프만-라 로슈 아게 | Pi3k 저해제인 gdc-0077로 암을 치료하는 방법 |
| AU2019321588C1 (en) | 2018-08-17 | 2026-05-14 | Genentech, Inc. | Diagnostic and therapeutic methods for the treatment of breast cancer |
| EP3863618A1 (en) * | 2018-10-08 | 2021-08-18 | F. Hoffmann-La Roche AG | Methods of treating cancer with pi3k alpha inhibitors and metformin |
| MX2022010425A (es) * | 2020-03-06 | 2022-09-07 | Olema Pharmaceuticals Inc | Metodos de tratamiento de enfermedades asociadas a los receptores de estrogenos. |
-
2022
- 2022-02-14 EP EP22713478.0A patent/EP4294395B1/en active Active
- 2022-02-14 ES ES22713478T patent/ES3030540T3/es active Active
- 2022-02-14 JP JP2023548874A patent/JP7904849B2/ja active Active
- 2022-02-14 CN CN202280015198.3A patent/CN117377472A/zh active Pending
- 2022-02-14 WO PCT/US2022/016270 patent/WO2022177844A1/en not_active Ceased
- 2022-02-14 TW TW111105232A patent/TWI808648B/zh active
- 2022-02-14 PL PL22713478.0T patent/PL4294395T3/pl unknown
-
2023
- 2023-08-15 US US18/449,800 patent/US20230381155A1/en active Pending